Ding Wang
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- PARP inhibition in cancer therapy
- Health Informatics top 2%
- Artificial Intelligence in Healthcare and Education
Papers in
- Co-authors
- James Gulley (5 shared papers)Alain Ravaud (3 shared papers)Jeffrey R. Infante (3 shared papers)Andrea Borghese Apolo (3 shared papers)Manish R. Patel (3 shared papers)Arnold Bruce Gelb (2 shared papers)Carolyn D. Britten (2 shared papers)Karen L. Kelly (4 shared papers)
- Journals
- Blood (4 papers)The Lancet Oncology (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)Journal of Molecular and Cellular Cardiology (3 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ding Wang
103 papers receiving 4.3k citations
Ding Wang's Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 1.4k
- Health Informatics 92
- Immunology 532
- Genetics 208
- Cancer Research 231
Countries citing papers authored by Ding Wang
This map shows the geographic impact of Ding Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ding Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ding Wang more than expected).
Fields of papers citing papers by Ding Wang
This network shows the impact of papers produced by Ding Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ding Wang. The network helps show where Ding Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ding Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 108 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Avelumab, an Anti–Programmed Death-Ligand 1 Antibody, In Patients With Refractory Metastatic Urothelial Carcinoma: Results From a Multicenter, Phase Ib Study Hit paper breakdown → | 2017 | 512 |
| 2 | Avelumab in metastatic urothelial carcinoma after platinum failure (JAVELIN Solid Tumor): pooled results from two expansion cohorts of an open-label, phase 1 trial Hit paper breakdown → | 2017 | 488 |
| 3 | Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study Hit paper breakdown → | 2020 | 389 |
| 4 | 2014 | 326 | |
| 5 | 2017 | 310 | |
| 6 | 2017 | 249 | |
| 7 | 2010 | 170 | |
| 8 | 2009 | 164 | |
| 9 | 2021 | 163 | |
| 10 | 2006 | 160 | |
| 11 | 2019 | 72 | |
| 12 | 2020 | 71 | |
| 13 | 2015 | 60 | |
| 14 | 2006 | 58 | |
| 15 | 2014 | 54 | |
| 16 | 2005 | 52 | |
| 17 | 2019 | 49 | |
| 18 | 2022 | 49 | |
| 19 | 2013 | 47 | |
| 20 | 2015 | 44 |
About Ding Wang
Ding Wang is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology, having authored 108 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Aortic aneurysm repair treatments (5 papers), Lung Cancer Treatments and Mutations (4 papers), Cancer-related molecular mechanisms research (3 papers), Chemotherapy-induced cardiotoxicity and mitigation (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Esophageal Cancer Research and Treatment (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Oncology (1.4k citations), Health Informatics (92 citations), Immunology (532 citations), Genetics (208 citations) and Cancer Research (231 citations). Ding Wang has collaborated with scholars based in China, United States and Germany. Frequent co-authors include James Gulley, Alain Ravaud, Jeffrey R. Infante, Andrea Borghese Apolo, Manish R. Patel, Arnold Bruce Gelb, Carolyn D. Britten, Karen L. Kelly, Kevin M. Chin and Raid M. Aljumaily. Their work appears in journals such as Blood, The Lancet Oncology, Journal for ImmunoTherapy of Cancer, Journal of Molecular and Cellular Cardiology and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.